Bank of America’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.65K | Buy |
1,250
+45
| +4% | +$347 | ﹤0.01% | 6175 |
|
|
2025
Q1 | $7.42K | Buy |
1,205
+8
| +0.7% | +$49 | ﹤0.01% | 6125 |
|
|
2024
Q4 | $6.11K | Sell |
1,197
-39
| -3% | -$199 | ﹤0.01% | 6148 |
|
|
2024
Q3 | $6.22K | Buy |
1,236
+34
| +3% | +$171 | ﹤0.01% | 6048 |
|
|
2024
Q2 | $4.94K | Buy |
1,202
+56
| +5% | +$230 | ﹤0.01% | 6120 |
|
|
2024
Q1 | $8.71K | Sell |
1,146
-3
| -0.3% | -$23 | ﹤0.01% | 6018 |
|
|
2023
Q4 | $9.58K | Sell |
1,149
-532
| -32% | -$4.44K | ﹤0.01% | 5961 |
|
|
2023
Q3 | $14.2K | Buy |
1,681
+96
| +6% | +$811 | ﹤0.01% | 5872 |
|
|
2023
Q2 | $15.1K | Sell |
1,585
-1,529
| -49% | -$14.5K | ﹤0.01% | 5893 |
|
|
2023
Q1 | $18.1K | Buy |
3,114
+1,075
| +53% | +$6.23K | ﹤0.01% | 5967 |
|
|
2022
Q4 | $16.5K | Sell |
2,039
-989
| -33% | -$8.02K | ﹤0.01% | 5988 |
|
|
2022
Q3 | $28K | Sell |
3,028
-1,422
| -32% | -$13.1K | ﹤0.01% | 6044 |
|
|
2022
Q2 | $50K | Sell |
4,450
-1,894
| -30% | -$21.3K | ﹤0.01% | 6030 |
|
|
2022
Q1 | $134K | Sell |
6,344
-377
| -6% | -$7.96K | ﹤0.01% | 5936 |
|
|
2021
Q4 | $195K | Buy |
6,721
+3,785
| +129% | +$110K | ﹤0.01% | 5704 |
|
|
2021
Q3 | $287K | Buy |
2,936
+2,025
| +222% | +$198K | ﹤0.01% | 5213 |
|
|
2021
Q2 | $119K | Sell |
911
-862
| -49% | -$113K | ﹤0.01% | 5641 |
|
|
2021
Q1 | $320K | Buy |
+1,773
| New | +$320K | ﹤0.01% | 5070 |
|